Published in Cell Res on December 04, 2012
Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis (2014) 1.80
Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ (2013) 1.60
Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis. Genome Biol (2015) 1.55
Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2. Genome Biol (2013) 1.47
Long noncoding RNAs in cell-fate programming and reprogramming. Cell Stem Cell (2014) 1.47
LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis (2014) 1.37
Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio (2014) 1.34
Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature. Nat Commun (2014) 1.18
Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol (2014) 1.16
Cell cycle regulation by long non-coding RNAs. Cell Mol Life Sci (2013) 1.10
7SL RNA represses p53 translation by competing with HuR. Nucleic Acids Res (2014) 1.06
Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential. Proc Natl Acad Sci U S A (2014) 1.03
Noncoding RNA in oncogenesis: a new era of identifying key players. Int J Mol Sci (2013) 1.03
LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. PLoS One (2014) 1.02
Long noncoding RNA plays a key role in metastasis and prognosis of hepatocellular carcinoma. Biomed Res Int (2014) 0.94
Databases for lncRNAs: a comparative evaluation of emerging tools. RNA (2014) 0.93
Regulatory non-coding RNAs in pluripotent stem cells. Int J Mol Sci (2013) 0.93
Long noncoding RNAs(lncRNAs) and the molecular hallmarks of aging. Aging (Albany NY) (2014) 0.92
ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Oncotarget (2016) 0.91
ncRDeathDB: A comprehensive bioinformatics resource for deciphering network organization of the ncRNA-mediated cell death system. Autophagy (2015) 0.90
Transforming growth factor-β-induced lncRNA-Smad7 inhibits apoptosis of mouse breast cancer JygMC(A) cells. Cancer Sci (2014) 0.89
Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment. Clin Cancer Res (2013) 0.89
Cell cycle, oncogenic and tumor suppressor pathways regulate numerous long and macro non-protein-coding RNAs. Genome Biol (2014) 0.88
Long noncoding RNAs in diseases of aging. Biochim Biophys Acta (2015) 0.88
Single-cell transcriptome analysis reveals dynamic changes in lncRNA expression during reprogramming. Cell Stem Cell (2015) 0.88
Regulation of breast tumorigenesis through acid sensors. Oncogene (2015) 0.87
Long Noncoding RNA Regulation of Pluripotency. Stem Cells Int (2015) 0.85
Enrichment of Human Stem-Like Prostate Cells with s-SHIP Promoter Activity Uncovers a Role in Stemness for the Long Noncoding RNA H19. Stem Cells Dev (2015) 0.84
Long Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy. PLoS One (2016) 0.83
Methods for the study of long noncoding RNA in cancer cell signaling. Methods Mol Biol (2014) 0.82
An emerging role for long non-coding RNA dysregulation in neurological disorders. Int J Mol Sci (2013) 0.82
The hnRNP-Q protein LIF2 participates in the plant immune response. PLoS One (2014) 0.81
Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis. Cell Death Dis (2016) 0.80
The DNA damage response: the omics era and its impact. DNA Repair (Amst) (2014) 0.80
Long Non-Coding RNAs Embedded in the Rb and p53 Pathways. Cancers (Basel) (2013) 0.80
Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma. Cancer Sci (2016) 0.80
Non-coding RNAs in pluripotency and neural differentiation of human pluripotent stem cells. Front Genet (2014) 0.80
Loss of TINCR expression promotes proliferation, metastasis through activating EpCAM cleavage in colorectal cancer. Oncotarget (2016) 0.78
The mitotic regulator Hec1 is a critical modulator of prostate cancer through the long non-coding RNA BX647187 in vitro. Biosci Rep (2015) 0.78
Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells. Cancers (Basel) (2017) 0.78
Regulatory non-coding RNA: new instruments in the orchestration of cell death. Cell Death Dis (2016) 0.77
Linc-RoR promotes c-Myc expression through hnRNP I and AUF1. Nucleic Acids Res (2015) 0.77
CTRL+INSERT: retrotransposons and their contribution to regulation and innovation of the transcriptome. EMBO Rep (2016) 0.77
Function of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score. Chin J Cancer Res (2014) 0.76
Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1. RNA Biol (2017) 0.76
Sam68 functions as a transcriptional coactivator of the p53 tumor suppressor. Nucleic Acids Res (2016) 0.76
Viruses, stemness, embryogenesis, and cancer: a miracle leap toward molecular definition of novel oncotargets for therapy-resistant malignant tumors? Oncoscience (2015) 0.75
A novel cytoprotective function for the DNA repair protein Ku in regulating p53 mRNA translation and function. EMBO Rep (2016) 0.75
An RNA matchmaker protein regulates the activity of the long noncoding RNA HOTAIR. RNA (2016) 0.75
Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma. Iran J Basic Med Sci (2016) 0.75
Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells. Oncotarget (2016) 0.75
Regulation of PCGEM1 by p54/nrb in prostate cancer. Sci Rep (2016) 0.75
Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions. EMBO Rep (2017) 0.75
LncRNAs: From Basic Research to Medical Application. Int J Biol Sci (2017) 0.75
The expanding regulatory universe of p53 in gastrointestinal cancer. F1000Res (2016) 0.75
A novel lncRNA, GASL1, inhibits cell proliferation and restricts E2F1 activity. Oncotarget (2017) 0.75
P-body proteins regulate transcriptional rewiring to promote DNA replication stress resistance. Nat Commun (2017) 0.75
Long Noncoding RNAs and RNA-Binding Proteins in Oxidative Stress, Cellular Senescence, and Age-Related Diseases. Oxid Med Cell Longev (2017) 0.75
Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients. Sci Rep (2017) 0.75
Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells. Int J Mol Sci (2017) 0.75
Long non-coding RNAs as novel biomarkers for breast cancer invasion and metastasis. Oncol Lett (2017) 0.75
LncRNA-mediated regulation of cell signaling in cancer. Oncogene (2017) 0.75
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (2004) 24.42
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (2010) 23.55
Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A (2009) 20.66
Long non-coding RNAs: insights into functions. Nat Rev Genet (2009) 19.61
Blinded by the Light: The Growing Complexity of p53. Cell (2009) 17.75
Long noncoding RNA as modular scaffold of histone modification complexes. Science (2010) 15.23
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature (2010) 13.82
A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell (2010) 12.27
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature (2011) 11.59
hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem (1993) 11.44
Molecular mechanisms of long noncoding RNAs. Mol Cell (2011) 11.44
lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature (2011) 11.31
Modes of p53 regulation. Cell (2009) 9.31
The first 30 years of p53: growing ever more complex. Nat Rev Cancer (2009) 8.00
DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev (1998) 7.78
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem (2007) 6.88
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol (2011) 6.54
The emergence of lncRNAs in cancer biology. Cancer Discov (2011) 6.32
The antisense transcriptomes of human cells. Science (2008) 6.29
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet (2011) 5.62
Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell (2003) 5.44
microRNAs join the p53 network--another piece in the tumour-suppression puzzle. Nat Rev Cancer (2007) 5.38
Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet (2010) 5.37
Structure of PTB bound to RNA: specific binding and implications for splicing regulation. Science (2005) 5.14
p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A (2009) 5.05
The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature (2004) 5.05
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell (2003) 4.96
RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci U S A (2003) 4.34
Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell (2005) 4.16
MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J (1996) 4.13
Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer (2009) 4.06
Signaling to p53: ribosomal proteins find their way. Cancer Cell (2009) 3.84
Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol Cell (2005) 2.99
Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res (2008) 2.67
Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. EMBO J (2004) 2.59
Negative feedback regulation of wild-type p53 biosynthesis. EMBO J (1995) 2.52
Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol Cell (2008) 2.46
Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol (2009) 2.34
Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors. Cancer Res (2005) 2.07
Locus-specific mutation databases: pitfalls and good practice based on the p53 experience. Nat Rev Cancer (2006) 2.05
Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein. Proc Natl Acad Sci U S A (2003) 2.02
5'-3'-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage. Genes Dev (2010) 1.64
Two internal ribosome entry sites mediate the translation of p53 isoforms. EMBO Rep (2006) 1.64
Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat Med (2011) 1.52
The identification of an internal ribosomal entry site in the 5'-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage. Oncogene (2006) 1.41
Control of insulin mRNA stability in rat pancreatic islets. Regulatory role of a 3'-untranslated region pyrimidine-rich sequence. J Biol Chem (2001) 1.39
Comparative genomics beyond sequence-based alignments: RNA structures in the ENCODE regions. Genome Res (2007) 1.37
Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas. Genes Dev (2011) 1.37
p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Gene (2007) 1.16
cAMP-dependent phosphorylation of PTB1 promotes the expression of insulin secretory granule proteins in beta cells. Cell Metab (2006) 1.14
Polypyrimidine tract binding protein regulates IRES-mediated translation of p53 isoforms. Cell Cycle (2008) 1.14
Gam1-associated alterations of drug responsiveness through activation of apoptosis. Mol Cancer Ther (2007) 1.12
Detection of microRNAs in cultured cells and paraffin-embedded tissue specimens by in situ hybridization. Methods Mol Biol (2011) 1.00
Small RNAs: Pseudogenes act as microRNA decoys. Nat Rev Cancer (2010) 0.80
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res (2008) 7.53
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem (2007) 6.88
Coupling of the nucleus and cytoplasm: role of the LINC complex. J Cell Biol (2005) 6.47
A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res (2004) 5.21
p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A (2009) 5.05
Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res (2009) 2.65
MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res (2009) 2.64
Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-mediated cell polarization. Proc Natl Acad Sci U S A (2009) 2.59
Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med (2006) 2.57
Micro-optical sectioning tomography to obtain a high-resolution atlas of the mouse brain. Science (2010) 2.47
LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res (2013) 2.38
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J Exp Med (2011) 2.38
Effect of Respiratory Therapy on the Prognosis of Chronic Heart Failure Patients Complicated With Sleep-Disordered Breathing - A Pilot Efficacy Trial. Circ J (2015) 2.31
The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol Cell (2006) 2.24
Hemodynamic-morphologic discriminants for intracranial aneurysm rupture. Stroke (2010) 2.12
The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res (2003) 2.01
miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res (2010) 1.99
miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res (2013) 1.94
Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res (2008) 1.92
Metabolic genes in cancer: their roles in tumor progression and clinical implications. Biochim Biophys Acta (2010) 1.88
Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci (Landmark Ed) (2010) 1.87
A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A (2004) 1.79
ABO3, a WRKY transcription factor, mediates plant responses to abscisic acid and drought tolerance in Arabidopsis. Plant J (2010) 1.74
Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One (2010) 1.70
Importance of dual induction tests for coronary vasospasm and ventricular fibrillation in patients surviving out-of-hospital cardiac arrest. Circ J (2009) 1.66
A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood (2014) 1.66
The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood (2011) 1.65
miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett (2010) 1.64
A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J Biol Chem (2010) 1.61
Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop (2011) 1.57
Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol (2011) 1.57
Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res (2007) 1.55
Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol (2012) 1.53
Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. J Biol Chem (2009) 1.53
Exogenous silicon (Si) increases antioxidant enzyme activity and reduces lipid peroxidation in roots of salt-stressed barley (Hordeum vulgare L.). J Plant Physiol (2003) 1.53
Plant phenomics and high-throughput phenotyping: accelerating rice functional genomics using multidisciplinary technologies. Curr Opin Plant Biol (2013) 1.52
Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer. Clin Cancer Res (2011) 1.51
Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug. Blood (2010) 1.48
Anti-cancer drugs targeting fatty acid synthase (FAS). Recent Pat Anticancer Drug Discov (2012) 1.46
Rho-kinase activation in patients with heart failure. Circ J (2013) 1.45
Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer. Dig Dis Sci (2013) 1.43
Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene (2004) 1.42
Rapid exchange of mammalian topoisomerase II alpha at kinetochores and chromosome arms in mitosis. J Cell Biol (2002) 1.42
Electrocardiographic characteristics of the variants of idiopathic left ventricular outflow tract ventricular tachyarrhythmias. J Cardiovasc Electrophysiol (2008) 1.41
RTE1 is a Golgi-associated and ETR1-dependent negative regulator of ethylene responses. Plant Physiol (2007) 1.39
Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med (2011) 1.38
Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta (2008) 1.36
Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells. Cancer Res (2006) 1.35
The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res (2006) 1.35
Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol Cancer (2009) 1.35
Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway. Carcinogenesis (2009) 1.35
Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology (2012) 1.34
Receptor signal output mediated by the ETR1 N terminus is primarily subfamily I receptor dependent. Plant Physiol (2006) 1.34
Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology (2009) 1.34
Roles of AKT signal in breast cancer. Front Biosci (2007) 1.33
MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin Cancer Res (2009) 1.32
Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer (2009) 1.32
Health care in China: improvement, challenges, and reform. Chest (2013) 1.31
miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res (2010) 1.29
FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis. Oncogene (2005) 1.29
IL-2 and autocrine IL-4 drive the in vivo development of antigen-specific Th2 T cells elicited by nematode parasites. J Immunol (2005) 1.29
RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer. Cancer Res (2008) 1.27
Requirements for the development of IL-4-producing T cells during intestinal nematode infections: what it takes to make a Th2 cell in vivo. Immunol Rev (2004) 1.24
Transposons inactivate biosynthesis of the nonribosomal peptide microcystin in naturally occurring Planktothrix spp. Appl Environ Microbiol (2006) 1.24
Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis. Clin Cancer Res (2009) 1.24
N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis. EMBO Mol Med (2012) 1.24
CADgene: a comprehensive database for coronary artery disease genes. Nucleic Acids Res (2010) 1.23
Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition. Onco Targets Ther (2013) 1.23
The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J Biol Chem (2007) 1.22
WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway. Mol Cancer Res (2012) 1.21
Hydrophilic Cu9S5 nanocrystals: a photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo. ACS Nano (2011) 1.21
Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology (2009) 1.21
Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Res (2008) 1.21
Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo. J Pharmacol Exp Ther (2009) 1.20
Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells. Cancer Lett (2007) 1.20
Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Res (2011) 1.20
Upconversion luminescent materials: advances and applications. Chem Rev (2014) 1.19
Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells. Nucleic Acids Res (2012) 1.19
Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J Biol Chem (2009) 1.19
Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion. J Exp Med (2010) 1.19
High-throughput measurement of rice tillers using a conveyor equipped with x-ray computed tomography. Rev Sci Instrum (2011) 1.18
Laser speckle imaging of blood flow in microcirculation. Phys Med Biol (2004) 1.18
Controllable N-doping of graphene. Nano Lett (2010) 1.18
miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition. J Natl Cancer Inst (2013) 1.18
Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt. J Am Soc Nephrol (2008) 1.18
Surface plasmon-coupled emission: what can directional fluorescence bring to the analytical sciences? Annu Rev Anal Chem (Palo Alto Calif) (2012) 1.17